Studying factors affecting outlook in glioblastoma
Part of Cancer clinical trials.
This study looks at how different factors, like the type of treatment and how much of the tumor was removed, affect the outlook for people with glioblastoma (a fast-growing brain tumor). It may help doctors better understand what leads to better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a glioma (a type of brain tumor) that is grade 2, 3, or 4.
- You had surgery to remove the tumor (any amount removed is okay).
- You received radiation therapy after surgery, with or without the chemotherapy drug temozolomide.
- You have MRI or CT scans from before and after your surgery and complete medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tumor samples to study what causes glioblastoma to return. It may help scientists find better treatments.
This trial studies different treatment regimens for people with glioblastoma that is either newly diagnosed or has come back. It aims to find which treatment approach works best for controlling the tumor and improving outcomes.
This study tracks people with glioblastoma (a type of aggressive brain tumor) over time to understand what affects their health and quality of life. If you take part, you'll fill out online surveys to help researchers learn how to improve care.
This study looks at how the brain's protective barrier works in people with glioblastoma. Researchers will study tumor tissue and use special scans to learn more, which might help improve future treatments.
This study is for adults with glioblastoma, a type of brain cancer. It is an observational study that will follow participants to learn more about the disease.
This study uses MRI scans to learn more about the biology of glioblastoma before and after surgery. It may help doctors understand how the tumor behaves and improve future treatments.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.